The Traderszone Network

New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market.

read more

read more

New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market.

read more

read more

New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market.

read more

read more

Real-Time Insights · Guaranteed Fast Delivery · Make Informed Decisions · Cloud Integration
Services: App Development, API Management, Analytics, Community Management, Big Data.

For DAX futures, IB quotes an initial margin of about 18,000 USD. However, when I tried to buy DAX today, the margin was double that, for a position size of 1. What’s up with that? It’s not the first time I see this, and IB’s margin calculations are are too complicated to explain, are infuriating, and make position sizing a shot in the dark.

For DAX futures, IB quotes an initial margin of about 18,000 USD. However, when I tried to buy DAX today, the margin was double that, for a position size of 1. What’s up with that? It’s not the first time I see this, and IB’s margin calculations are are too complicated to explain, are infuriating, and make position sizing a shot in the dark.

For DAX futures, IB quotes an initial margin of about 18,000 USD. However, when I tried to buy DAX today, the margin was double that, for a position size of 1. What’s up with that? It’s not the first time I see this, and IB’s margin calculations are are too complicated to explain, are infuriating, and make position sizing a shot in the dark.